{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:45:46Z","timestamp":1780735546895,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.suronc.2021.101636","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:16:23Z","timestamp":1626876983000},"page":"101636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5644-3706","authenticated-orcid":false,"given":"Diego","family":"Flores-Funes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Aguilar-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mart\u00ednez-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ib\u00e1\u00f1ez-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Carrasco-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Gil-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Asunci\u00f3n","family":"Chaves-Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ayala-De La Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Nieto-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Aguayo-Albasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.suronc.2021.101636_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs No axillary dissection in women with invasive breast cancer and sentinel node metastasis","volume":"305","author":"Giuliano","year":"2011","journal-title":"J. Am. Med. Assoc."},{"issue":"10","key":"10.1016\/j.suronc.2021.101636_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis","volume":"318","author":"Giuliano","year":"2017","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.suronc.2021.101636_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2021.101636_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN guidelines insights: breast cancer, version 1.2017","volume":"15","author":"Gradishar","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"14","key":"10.1016\/j.suronc.2021.101636_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer","volume":"310","author":"Boughey","year":"2013","journal-title":"J. Am. Med. Assoc."},{"issue":"9","key":"10.1016\/j.suronc.2021.101636_bib6","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis","volume":"20","author":"Park","year":"2013","journal-title":"Ann. Surg Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2021.101636_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","article-title":"Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment","volume":"42","author":"Galimberti","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2021.101636_bib8","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann. Surg Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2021.101636_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2021.101636_bib10","first-page":"299","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with an initial diagnosis of cytology-proven lymph node-positive breast cancer","volume":"16","author":"Enokido","year":"2016","journal-title":"Clin. Breast Canc."},{"issue":"4","key":"10.1016\/j.suronc.2021.101636_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann. Surg."},{"issue":"10","key":"10.1016\/j.suronc.2021.101636_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2021.101636_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.suronc.2019.05.019","article-title":"Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: preliminary results","volume":"30","author":"Flores-Funes","year":"2019","journal-title":"Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2021.101636_bib14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.breast.2013.06.004","article-title":"Pre-operative staging of the axilla in primary breast cancer. Byredefining the abnormal appearing node can we reduce investigations without affecting overall treatment?","volume":"22","author":"Amonkar","year":"2013","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.suronc.2021.101636_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Canc."},{"issue":"2","key":"10.1016\/j.suronc.2021.101636_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0000000000001213","article-title":"The value of isosulfan blue dye in addition to isotope scanning in the identification of the sentinel lymph node in breast cancer patients with a positive lymphoscintigraphy: a randomized controlled trial (ISRCTN98849733)","volume":"262","author":"O'Reilly","year":"2015","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2021.101636_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2137-0","article-title":"The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic review","volume":"16","author":"He","year":"2016","journal-title":"BMC Canc."},{"issue":"28","key":"10.1016\/j.suronc.2021.101636_bib18","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2021.101636_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2021.101636_bib22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.suronc.2021.101636_bib23","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.suronc.2021.101636_bib24","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2214\/AJR.16.16545","article-title":"Radiologic mapping for targeted axillary dissection: needle biopsy to excision","volume":"207","author":"Shin","year":"2016","journal-title":"Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.suronc.2021.101636_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","article-title":"Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial","volume":"150","author":"Caudle","year":"2015","journal-title":"JAMA Surg."},{"issue":"2","key":"10.1016\/j.suronc.2021.101636_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00268-017-4171-8","article-title":"Feasibility of preoperative axillary lymph node marking with a clip in breast cancer patients before neoadjuvant chemotherapy: a preliminary study","volume":"42","author":"Kim","year":"2018","journal-title":"World J. Surg."},{"issue":"9","key":"10.1016\/j.suronc.2021.101636_bib27","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","article-title":"Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy","volume":"44","author":"Hartmann","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2021.101636_bib28","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ejso.2019.12.007","article-title":"Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy","volume":"46","author":"Balasubramian","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2021.101636_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/ans.15604","article-title":"Targeted axillary dissection after neoadjuvant systemic therapy in patients with node-positive breast cancer","volume":"90","author":"Kanesalingam","year":"2020","journal-title":"ANZ J. Surg."},{"issue":"2","key":"10.1016\/j.suronc.2021.101636_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients","volume":"261","author":"Donker","year":"2015","journal-title":"Ann. Surg."},{"issue":"12","key":"10.1016\/j.suronc.2021.101636_bib31","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.crad.2019.08.018","article-title":"A prospective, single-arm, multicentre clinical evaluation of a new localisation technique using non-radioactive Magseeds for surgery of clinically occult breast lesions","volume":"74","author":"Thekkinkattil","year":"2019","journal-title":"Clin. Radiol."},{"issue":"4","key":"10.1016\/j.suronc.2021.101636_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2214\/AJR.19.21378","article-title":"Feasibility of magnetic seeds for preoperative localization of axillary lymph nodes in breast cancer treatment","volume":"213","author":"Greenwood","year":"2019","journal-title":"AJR Am. J. Roentgenol."},{"issue":"10","key":"10.1016\/j.suronc.2021.101636_bib33","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1245\/s10434-018-6575-6","article-title":"Improved false-negative rates with intraoperative identification of clipped nodes in patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"25","author":"Cab\u0131o\u011flu","year":"2018","journal-title":"Ann. Surg Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2021.101636_bib34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann. Surg Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740421001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740421001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:22:41Z","timestamp":1760757761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740421001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":32,"alternative-id":["S0960740421001250"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2021.101636","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2021.101636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101636"}}